Advertisement

    We only need a few more clicks to be able to show the most read stories for this topic. Take a look at the latest headlines below and help us out by clicking on what you find interesting!

    In the last 4 hours
    In the last 8 hours
    Yesterday
    Alarming Rise in Liver Disease Amid Global Fatty Liver Day 2025 American Journal of Managed Care22:41 12-Jun-25
    RGX-202 Gene Therapy Improves DMD Trajectory, Biomarkers American Journal of Managed Care22:31 12-Jun-25
    Immunotherapy Timing Does Not Significantly Affect Outcomes in ES-SCLC American Journal of Managed Care18:38 12-Jun-25
    Trends in sedentary behaviour. . . and other research British Medical Journal11:50 12-Jun-25
    In the last 7 days
    TPIP a Potential Game-Changer for Prostanoid Therapy in PAH American Journal of Managed Care17:11 11-Jun-25
    ACS announces 2025 Heroes of Chemistry American Chemical Society (Press Release)14:39 11-Jun-25
    Tufts Chemists Design a Next Generation Weight Loss Drug Newswise (Press Release)19:17 10-Jun-25
    Real-World Use of GLP-1s Yields Less Weight Loss Than Clinical Trials American Journal of Managed Care15:57 10-Jun-25
    New Era of CLL Treatments Brings Changes to Use of HSCT American Journal of Managed Care21:48 9-Jun-25
    People Living With HIV Communicate Less With Health Care Providers American Journal of Managed Care18:34 9-Jun-25
    Week 53 Mounjaro Update: Jacked Lab Monkeys & Med Purgatory The Nittany Turkey (Weblog)14:37 9-Jun-25
    The Drivers of Age-Related Diseases Ground Truths19:59 8-Jun-25
    Spleen Stiffness Measurement Linked With Portal Hypertension in MPNs American Journal of Managed Care14:31 7-Jun-25
    C5aR1 Flagged as Biomarker in Cutaneous Squamous Cell Carcinoma American Journal of Managed Care12:39 7-Jun-25
    Biomarker-Adapted Treatment Effective in High-Risk LBCL American Journal of Managed Care01:58 7-Jun-25
    Novel Biomarkers May Inform Prognosis in SCLC American Journal of Managed Care01:17 7-Jun-25
    This drug can treat diabetes and obesity much better Knowridge Science Report11:24 6-Jun-25
    In the last month
    view more headlines
    13 Jun 05:12

    About our Tirzepatide news

    Latest news on Tirzepatide, a drug that is being developed as a potential treatment for obesity and type 2 diabetes. It is a synthetic hormone that is designed to mimic the effects of natural hormones called incretins, which help to lower blood sugar and reduce appetite. Tirzepatide has shown promise in clinical trials, producing significant weight loss in people with obesity or type 2 diabetes. It is administered as a once-weekly injection, and it is believed to work by increasing the production of a hormone called GLP-1, which helps to regulate appetite and insulin production. Tirzepatide is currently in late-stage clinical trials, and it is expected to be considered for regulatory approval in the coming years.


    Publication filters

    Headline Density

    Sorry, no headlines or news topics were found. Please try different keywords.